TGFBR3 (Betaglycan) Gene

Transforming Growth Factor Beta Receptor 3: A Coreceptor in TGF-β Signaling

Gene Information Card

Symbol TGFBR3
Full Name Transforming Growth Factor Beta Receptor 3
Gene Type protein-coding
Chromosomal Location 1p22.1
NCBI Gene ID 7049 ncbi.nlm.nih.gov/gene/7049
Ensembl ID ENSG00000069702
UniProt ID Q03167
OMIM ID 600742
HGNC ID 11774
Aliases betaglycan, BGCAN, TGF-beta receptor type III

Description

TGFBR3 encodes betaglycan, a membrane-anchored proteoglycan that functions as a coreceptor for transforming growth factor beta (TGF-β) superfamily ligands. It presents TGF-β to the type II receptor, enhancing signaling. Betaglycan also exists in soluble form and modulates ligand availability. The gene is widely expressed and plays roles in cell growth, differentiation, and immune regulation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Loeys-Dietz syndrome 5 Loss-of-function mutations in TGFBR3 impair TGF-β signaling, leading to aortic aneurysm and connective tissue abnormalities. ClinVar; OMIM #615582
Hereditary hemorrhagic telangiectasia (HHT) TGFBR3 variants disrupt endothelial TGF-β signaling, contributing to vascular malformations. ClinVar; PMID: 30523342
Cancer (various) Reduced TGFBR3 expression or somatic mutations alter TGF-β tumor suppression, promoting invasion and metastasis. COSMIC; PMID: 21575862

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 12.3 Medium
Lung 9.8 Medium
Kidney 8.5 Medium
Liver 4.2 Low
Brain 3.1 Low
Cell Line Expression
Cell Line nTPM Notes
HUVEC (endothelial) 15.2 High expression
HEK293 (embryonic kidney) 7.6 Moderate
A549 (lung carcinoma) 5.4 Reduced vs normal lung
MCF7 (breast cancer) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1573C>T (p.Arg525*) Nonsense <0.01% Loss of function; associated with Loeys-Dietz syndrome
c.2146G>A (p.Gly716Ser) Missense <0.01% Impaired ligand binding; reported in HHT
c.1234_1235del (p.Leu412fs) Frameshift <0.01% Truncated protein; loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and splice-site mutations that reduce or abolish betaglycan expression or ligand-binding capacity.

Gain of Function (GOF)

Not well documented; no recurrent activating mutations reported in COSMIC or ClinVar.

Dominant Negative (DN)

Missense mutations that produce a defective coreceptor capable of interfering with wild-type TGFBR3 function, though evidence is limited.

Pathways

TGF-beta signaling pathway (KEGG: hsa04350)
Regulation of epithelial-to-mesenchymal transition (EMT)
Endoglin/TGFBR3 coreceptor complex in angiogenesis

Protein Summary

Betaglycan (TGFBR3) is a 849-amino-acid transmembrane proteoglycan with a large extracellular domain containing heparan sulfate and chondroitin sulfate chains. It binds TGF-β isoforms (TGFB1, TGFB2, TGFB3) with high affinity and presents them to TGFBR2, thereby modulating downstream SMAD signaling. The protein also undergoes ectodomain shedding to generate soluble betaglycan, which can sequester TGF-β. Betaglycan is critical for cardiovascular development, immune homeostasis, and tumor suppression.

Related Products

Product name Cat.No. Species Gene ID
TGFBR3 Knockout HEK293 Cell Line EDJ-KQ2915 Human 7049 Details Get a Quote
TGFBR3L Knockout HEK293 Cell Line EDJ-KQ14938 Human 100507588 Details Get a Quote
TGFBR3 Knockout A-549 Cell Line EDJ-KQ24006 Human 7049 Details Get a Quote
TGFBR3 Knockout HCT 116 Cell Line EDJ-KQ24007 Human 7049 Details Get a Quote
TGFBR3 Knockout HeLa Cell Line EDJ-KQ24008 Human 7049 Details Get a Quote
TGFBR3L Knockout HCT 116 Cell Line EDJ-KQ46622 Human 100507588 Details Get a Quote
TGFBR3L Knockout HeLa Cell Line EDJ-KQ46623 Human 100507588 Details Get a Quote
TGFBR3L Knockout A-549 Cell Line EDJ-KQ69401 Human 100507588 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: